GEN recently published a list of the top 10 Wall Street Winners of 2013–the ten best stock performers of the year in biotech, pharma, tools/tech, and services (CROs). Which of the companies on our list do you think is most likely to remain victorious on Wall Street?
Poll Question:
Which of our Top 10 Wall Street Winners of 2013 do you think is most likely to keep increasing in value?
Acadia Pharmaceuticals
26
BioCryst Pharmaceuticals
9
Catalyst Pharmaceutical Partners
8
Galectin Therapeutics
10
Gentium
11
Idera Pharmaceuticals
9
Insys Therapeutics
9
Keryx Biopharmaceuticals
5
Prothena
6
Puma Biotechnology
13